“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Ardelyx, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA (tenapanor) and XPHOZAH (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3
| C-Level 2 | VP - Level17 |
| Director213 | Manager33 |
| Others71 | |
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | Dallas, TX | presence, integrity, compliance, k, collaboration |
| Application Development | Minneapolis, MN | communication, e, integrity, compliance, collaboration, k, analytics, operations, financial |
| Application Development | Paterson, NJ | presence, integrity, compliance, k, collaboration |
| Application Development | United States | communication, e, data analysis, compliance, access management, k, bi, share, analytics, visualization, operations, workflow |
| Application Development | Waltham, MA | quality assurance, communication, continuous improvement, risk, audit, data analysis, operating procedures, compliance, assessment, security, collaboration, k, integrity, operations |
Ardelyx, Inc looking to hire in ERP Implementation in Newark, CA
Ardelyx, Inc looking to hire in Embedded Design in Newark, CA
Ardelyx, Inc looking to hire in Cloud Migration in Newark, CA
Amazon connect
Cmms
Gcp
Google ads
Netsuite
Acceptance testing
Access management
Accessibility
Active directory
Analytics
DescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreDescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreDescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreDescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreDescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreDescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreDescriptionArdelyx is a publicly traded commercial biopharmaceutical company founded with a missi...
View MoreArdelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA (tenapanor) and XPHOZAH (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3
Ardelyx, inc operates in the Biotechnology research industry.
Ardelyx, inc's revenue is $333.62m
Ardelyx, inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.